Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,127 public trials 3,991 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

NCT03858205

Conditions
Blood Protein Disorders, Bone Pain, Cardiovascular Diseases, +15 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View Trial Details
Recruiting

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

NCT05430971

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Seattle Children's Cancer and Blood Disorders Center Seattle, Washington, United States
  • Hematology Center named after prof. R. Yeolyan Yerevan, Armenia
View all 22 locations
View Trial Details
Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT06131801

Conditions
ALL, AML, Acute Lymphocytic Leukemia, +50 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

Sickle Cell Clinical Research and Intervention Program

NCT02098863

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Children's Hospital of Illinois at OSF-Saint Francis Medical Center Peoria, Illinois, United States
  • Our Lady of the Lake Regional Medical Center Baton Rouge, Louisiana, United States
  • Novant Health Hemby Children's Hospital Charlotte, North Carolina, United States
  • Regional One Health, Diggs-Kraus Sickle Cell Center Memphis, Tennessee, United States
View Trial Details
Recruiting

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

NCT07252050

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Manning Family Children's New Orleans, Louisiana, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

NCT05243797

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Banner University Medical Center Tucson, University of Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California-Davis Cancer Center Sacramento, California, United States
  • University of California, San Diego (UCSD) Medical Center San Diego, California, United States
View all 212 locations
View Trial Details

Related conditions